PODD · NASDAQ · STOCK
Insulet (PODD) Stock Analysis
$141.09
52W $126.40 – $354.88
62/100
$9.62B
25.9
1.10
Is PODD Bullish or Bearish?
Bullish.
Innellis AI committee rates Insulet Corporation (PODD) Buy with a composite score of 62/100
, based on 5 analysts with 60% agreement.
Last updated October 16, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +12.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -7.17 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 29.4% yoy -- genuine top-line momentum. Portfolio Manager remains cautious — sector concentration is already high (hhi 2739.42). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 17.4% shows genuine earnings power backing the valuation — Value
- Revenue growing 29.4% YoY -- genuine top-line momentum — Growth
- EPS growing 66.8% YoY — Growth
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 25.4 is moderate-to-rich — Value
- Price-to-book of 13.2x prices in significant intangible value — Value
- Price structure making lower highs and lower lows — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 16, 2026
Overall Committee Score
62/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 21%
of 192 Healthcare peers
Value Analyst
neutral
48
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 17.4% shows genuine earnings power backing the valuation
− P/E of 25.4 is moderate-to-rich
Growth Analyst
bullish
84
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 29.4% YoY -- genuine top-line momentum
Technical Analyst
neutral
56
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2739.42)
Investment Thesis Evolution
Committee score moved marginally from 62.2 to 62.2.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- Portfolio Manager: +1 bearish signal(s).
Comparing 2026-10-15 to 2026-10-16 (1 day apart).
Technical Analysis
RSI (14)
58.5
Neutral
MACD Histogram
0.904
Bullish Momentum
Trend Direction
Downtrend
Weekly: Downtrend
Market Structure
Mixed
Support
$138.81
Resistance
$172.91
Bollinger %B
0.76
Inside Bands
Price vs Moving Averages
EMA 9
$136.30
Above
EMA 21
$136.78
Above
EMA 50
$141.53
Below
EMA 200
$183.30
Below
Fundamental Analysis
Valuation
58
Growth
90
Profitability
80
Financial Health
96
Cash Flow
70
Valuation
P/E Ratio
25.9×
P/B Ratio
6.76×
PEG Ratio
0.44
Dividend Yield
0.00%
52W High
$354.88
52W Low
$126.40
Quality & Growth
ROE
1630.8%
ROA
774.5%
Gross Margin
7107.9%
Operating Margin
1689.2%
Revenue Growth YoY
—
Debt / Equity
0.67
AI Fundamental Assessment
P/E ratio of 25.9 (moderate relative to a 15-40x range); Price-to-book of 6.8x; PEG ratio of 0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 16.3%; Return on assets of 7.7%; Net margin of 12.3%; Gross margin of 71.1%; Current ratio of 2.48 (healthy short-term liquidity); Debt-to-equity of 0.67; Free cash flow per share is positive (4.30); Most recent quarter beat estimates by 12.2%; 5 consecutive earnings beats; EPS growth accelerating (-8.4% -> +16.9% QoQ); Average YoY EPS growth of 41.9%; Analyst estimates flat over recent quarters
Get the Full PODD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →